France· FR:66477109
LEVOSIMENDAN ACCORD 2,5 mg/mL, solution à diluer pour perfusion
A levosimendan product containing lévosimendan, registered in France by ACCORD HEALTHCARE FRANCE. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Levosimendan is registered in 14 of 19 countries.
Countries holding a registration under ATC C01CX08 (levosimendan), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Levosimendan · ATC C01CX08
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LÉVOSIMENDAN
- Manufacturer
- ACCORD HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- C01CX08
- ATC class
- Levosimendan
- Defined daily dose
- 11 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550865051 flacon en verre de 5 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levosimendan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsLevosimendan Eureco-Pharma 2,5 mg/ml, concentraat voor oplossing voor infusieEureco-Pharma B.V.
- SpainLEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- FinlandLevosimendan AltanAltan Pharma Ltd
- CzechiaLEVOSIMENDAN AVMCAV Medical CZ s.r.o., Praha
- SwedenLevosimendan Altan 2,5 mg/ml Koncentrat till infusionsvätska, lösningAltan Pharma Limited
- GermanyLevosimendan AccordAccord Healthcare B.V.
- PolandLevosimendan AccordAccord Healthcare Polska Sp. z o.o.
- SwitzerlandLevosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungIDEOGEN AG
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cordenova, Levosimendan Accord
- Belgium · Levosimendan Kabi, Levosimendan Kalceks
- Bulgaria · Левосимендан Калцекс, Симдакс
- Cyprus · Levosimendan Win Medica, Simdax
- Czechia · Levosimendan Fmk, Levosimendan Kalceks
- Germany · Levosimendan Accord, Levosimendan Altan
- Denmark · Levosimendan, Levosimendan Amdipharm
- Estonia · Levosimendan Auxilia, Levosimendan Kalceks
- Spain · Levosimendán Accord, Levosimendán Altan
- Finland · Levosimendan Amdipharm, Levosimendan Bioglan
- Greece · Levosimendan Win Medica, Simdax
- Croatia · Levosimendan Alpha-Medical, Levosimendan Kalceks
- Hungary · Levosimendan Kalceks, Levosimendan Stada
- Ireland · Levosimendan Kalceks
- Iceland · Levosimendan Stada, Simdax
- Italy · Levosimendan Accord, Levosimendan Altan
- Lithuania · Levosimendan Kalceks
- Latvia · Levosimendan Kalceks
- Netherlands · Levosimendan Carinopharm, Levosimendan Kalceks
- Norway · Levosimendan Amdipharm, Levosimendan Bioglan
- Poland · Levosimendan Accord, Levosimendan Farmak
- Portugal · Levossimendano Accord, Levossimendano Altan
- Romania · Levatrop, Levosimendan
- Sweden · Levosimendan Amdipharm, Levosimendan Bioglan
- Slovenia · Levosimendan Carinopharm, Levosimendan Kalceks
- Slovakia · Levosimendan Fmk, Levosimendan Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c504f317-289f-42b5-86c6-b03d9d46c312 GET /v1/drugs/c504f317-289f-42b5-86c6-b03d9d46c312?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66477109",
"date_amm": "2021-12-30",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "LÉVOSIMENDAN",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about levosimendan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.